Discover how targeting DNA Damage Response and anti-apoptosis genes offers new hope for treating Acute Myeloid Leukaemia in elderly patients through synergistic lethality.
Discover how BH3 profiling predicts AML patient response to venetoclax-based treatments through cellular apoptosis mechanisms and precision medicine approaches.